Advanced glycation end products and diabetic cardiovascular disease.
about
Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular ComplicationsQuantitative analysis of histone modifications: formaldehyde is a source of pathological n(6)-formyllysine that is refractory to histone deacetylasesEffects of the small molecule SIRT1 activator, SRT2104 on arterial stiffness in otherwise healthy cigarette smokers and subjects with type 2 diabetes mellitusOptoacoustic detection of tissue glycation.Lifestyle and Advanced Glycation End Products (AGEs) Burden: Its Relevance to Healthy AgingAdvanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation.Dietary fat quantity and quality modifies advanced glycation end products metabolism in patients with metabolic syndrome.Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways.Usual intake of added sugars and lipid profiles among the U.S. adolescents: National Health and Nutrition Examination Survey, 2005-2010.Oxidative stress in aging human skin.Skin Autofluorescence in Systemic Sclerosis Is Related to the Disease and Vascular Damage: A Cross-Sectional Analytic Study of Comparative GroupsImpact of Admission Glycosylated Hemoglobin A1c on Angiographic Characteristics and Short Term Clinical Outcomes of Nondiabetic Patients with Acute ST-Segment Elevation Myocardial Infarction.An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetesPlasma Levels of Advanced Glycation End Products Are Related to the Clinical Presentation and Angiographic Severity of Symptomatic Lower Extremity Peripheral Arterial Disease.SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands togetherMolecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.Dietary consumption of meat, fat, animal products and advanced glycation end-products and the risk of Barrett's oesophagus.Impact of glycemic control on heart rate variability in youth with type 1 diabetes: the SEARCH CVD study.Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease.Sugars and risk of mortality in the NIH-AARP Diet and Health Study.Protective effects of physiological testosterone on advanced glycation end product‑induced injury in human endothelial cells.Honey and Wound Healing: An Update.Dietary consumption of advanced glycation end products and risk of metabolic syndrome.Hyperglycemia-related advanced glycation end-products is associated with the altered phosphatidylcholine metabolism in osteoarthritis patients with diabetesMetformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression.Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial.Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway.Recombination and functional studies of a dual-action peptide for diabetes.Antichaperone activity and heme degradation effect of methyl tert-butyl ether (MTBE) on normal and diabetic hemoglobins.Reactivity, Selectivity, and Reaction Mechanisms of Aminoguanidine, Hydralazine, Pyridoxamine, and Carnosine as Sequestering Agents of Reactive Carbonyl Species: A Comparative Study.Advanced glycation end products as a source of artifacts in immunoenzymatic methods.Impact of Maillard reaction products on nutrition and health: Current knowledge and need to understand their fate in the human digestive system.Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Cohort Study.Curcumin against advanced glycation end products (AGEs) and AGEs-induced detrimental agents.Daily intake of vitamin D- or calcium-vitamin D-fortified Persian yogurt drink (doogh) attenuates diabetes-induced oxidative stress: evidence for antioxidative properties of vitamin D.Soluble receptor for advanced glycation end products and increased aortic stiffness in the general population.Insulin resistance in cavefish as an adaptation to a nutrient-limited environment.Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules.Pioglitazone alleviates inflammation in diabetic mice fed a high-fat diet via inhibiting advanced glycation end-product-induced classical macrophage activation.Advanced Glycation End Products Enhance Murine Monocyte Proliferation in Bone Marrow and Prime Them into an Inflammatory Phenotype through MAPK Signaling.
P2860
Q26859263-90BCC0F7-BA2A-4A7E-9F71-8C0A6944FB15Q28487129-7B1E723A-7372-4256-BE93-AE165110890CQ28602255-F09165F9-5C5E-4093-B12C-C835B0090345Q30402345-9D3EEFA3-142E-40A0-929F-9C6C41FE6779Q33680171-1444156E-A9FB-4D9F-88C6-E9A10A3579E3Q34350918-5E9CE78F-2643-47BA-BE2E-F02FA8B5EBCBQ34680886-CF106C2B-8089-4F54-801E-685EA15F4D04Q34776889-CF729CBF-403C-48B9-9629-012B147162EFQ35827768-4ED913CB-0D3C-43EE-AACA-3968C1F912A6Q35833994-B80C148E-9DFD-4B4C-9A0E-642EC8E4F3FCQ35924733-F33730DD-F367-4B6E-BE0D-3C6DFF6D366CQ36368989-FA01E896-0FA2-44D8-8C7C-B7A07749D04CQ36567296-EEB69AD8-140C-4C3B-B94D-656E24A0A535Q36593852-754AF41F-82C1-4A5E-BEC1-3023D41F1FB3Q36867464-669BDE5D-0AE9-4CC2-94AD-B9F95E9C4DFFQ37254899-C3027848-9484-453F-AA89-828343F5A40BQ37262909-CF1F7A43-4BDE-4413-85D6-E68A97EC91A4Q37404303-8672F9F0-D655-4681-A78C-193E31A3CE8EQ37567574-F9AC06A4-39A7-4621-B4FD-F5096034420FQ37700603-1EEA3C80-D2E1-4CB6-881B-E1102863BF8AQ37722123-A761660B-A88B-4AAE-9B4D-10930C0127E0Q39072340-CA881E16-2F7D-4957-93EF-2A798D1E7720Q40018926-C5AACB5B-1403-4178-ACD8-D093E195CD15Q41230337-2CD3A5A2-9C82-43BB-80E6-A8C3A93A04B6Q41430394-16FBA017-88E7-4F53-B8DC-CDC086CDEB2EQ41836455-06813F5C-D920-4F49-8834-E0828EAAED62Q42068283-9DFAC2DD-4BF6-427E-BEF9-4820DC2E2898Q44227850-48490C26-C85D-470B-8859-3271C0679085Q46450399-3DA781CC-ECE4-4465-A663-976A30CA1468Q46593878-17592A82-9C7A-4867-8B83-CAA7C3BB7996Q47197460-1A862E89-25C4-4676-B668-BFAA4E4FB54FQ47810744-05909A5E-D8CC-44CE-B3B6-BB8844F33638Q48324923-9184D67F-41AD-4495-8315-F6A370BE0CA3Q49554778-88889BB9-B097-4905-90BA-F09908C5492CQ50856187-43E57F5C-4FE9-425F-A3F7-9E96C2829634Q51620241-2FD63E7F-3222-4BD0-BAF2-B6028F59184AQ52644784-DACCAD41-965F-4A75-9B75-47229D1D34C4Q52673327-38CFFC92-0D67-4242-9EAD-62569F7DE618Q53125792-9829A43D-4FFF-4673-9ABB-18F75A65465CQ55228553-CC37571F-4E08-4694-91EF-98BDF811740E
P2860
Advanced glycation end products and diabetic cardiovascular disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Advanced glycation end products and diabetic cardiovascular disease.
@ast
Advanced glycation end products and diabetic cardiovascular disease.
@en
Advanced glycation end products and diabetic cardiovascular disease.
@nl
type
label
Advanced glycation end products and diabetic cardiovascular disease.
@ast
Advanced glycation end products and diabetic cardiovascular disease.
@en
Advanced glycation end products and diabetic cardiovascular disease.
@nl
prefLabel
Advanced glycation end products and diabetic cardiovascular disease.
@ast
Advanced glycation end products and diabetic cardiovascular disease.
@en
Advanced glycation end products and diabetic cardiovascular disease.
@nl
P1433
P1476
Advanced glycation end products and diabetic cardiovascular disease.
@en
P2093
Anand Prasad
Peter Bekker
P304
P356
10.1097/CRD.0B013E318244E57C
P577
2012-07-01T00:00:00Z